1 completed, 1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow ABSSSI: new trials by email Literature Review of ABSSSI trials Research Report on ABSSSI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis Tebipenem Pivoxil Hydrobromide - Diabetes, Wound Infection | Phase 1 | Completed | Hartford Hospital | 12 | 2021-07-01 | 2023-10-23 |
| Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline MRSA Infection, Bacteremia | Unknown | CPL Associates | 30 | 2012-12-01 | 2012-11-12 |
Bacteremia (1) · Diabetes Mellitus (1) · Pneumonia (1) · Wound Infection (1)
Infections (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Inflammation (1) · Lung Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Sepsis (1) · Systemic Inflammatory Response Syndrome (1)
CPL Associates (1) · Hartford Hospital (1)
United States (2)
Jerome J Schentag, Pharm.D. (1) · Tomefa E Asempa, PharmD (1)